中文名称 | (1R,3S,Z)-5-((E)-2-((1S,3aS,7aS)-1-((S)-1-(3-羟基-3-甲基丁氧基)乙基)-7a-甲基六氢-1H-茚-4(2H)-亚基)亚乙基)-4-亚甲基环己烷-1,3-二醇; 马沙骨化醇 ; 玛莎骨化醇 |
---|---|
英文名称 | Maxacalcitol (Synonyms: 22-Oxacalcitriol) |
CAS号 | 103909-75-7 |
分子式 | C26H42O4 |
分子量 | 418.61 |
MDL | MFCD00871502 |
外观 | White to off-white powder |
储存条件 | 4°C, protect from light, stored under nitrogen |
Maxacalcitol, a vitamin D3 analog, acts as a potent orally active VDR agonist with minimal calcemic effects. It inhibits PTH mRNA expression and bone resorption, making it a promising candidate for hyperparathyroidism research. Additionally, Maxacalcitol exhibits anti-tumor activity by suppressing cell proliferation, migration, and inducing apoptosis through GPx-1 inhibition. Its unique properties suggest potential utility in treating psoriasis and underscore its significance in bone health and cancer research.
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft